Sanara MedTech Inc. - Common Stock, $0.001 par value (SMTI)

CUSIP: 79957L100

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class
Equity / Common Stock, $0.001 par value
Total 13F shares
381,841
Total 13F value
$17,371,120
Holder snapshot 6 signals
Share change
+46,990
SEC-reported price per share
$45.50
Number of holders
31
Value change
+$2,570,809
Number of buys
16
Number of sells
8
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
8,944,624

Security key

79957L100

Report period

Q4 2022

Institutions

31

Top holders

10

SMTI full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Sanara MedTech Inc. SEC filings Sanara MedTech Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SMTI - Sanara MedTech Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
02 Dec 2022
13F 3/4/5 Highest disclosed value: $2,740,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

VANGUARD GROUP INC has the largest disclosed position value at $2.74M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value Top 5
VANGUARD GROUP INC $2.74M
Informed Momentum Co LLC $1.63M
Christopher A. Morrison $1.15M
J. Michael Carmena $908.8K
Diametric Capital, LP $882K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$2,740,000
92,298 shares
 — 30 Sep 2022
Informed Momentum Co LLC
13F
Company
13F
—
denominator unverified
$1,629,000
54,860 shares
 — 30 Sep 2022
Christopher A. Morrison
3/4/5
President - Telehealth Svcs.
3/4/5
—
denominator unverified
$1,152,115
28,032 shares
 — 01 Jan 2022
J. Michael Carmena
3/4/5
Principal Executive Officer, Director
3/4/5
—
denominator unverified
$908,844
22,113 shares
 — 22 Dec 2021
Diametric Capital, LP
13F
Company
13F
—
denominator unverified
$882,000
29,695 shares
 — 30 Sep 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$783,000
26,405 shares
 — 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
31
Shares
381,841
Rows available
31
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q2 2026 Across Filers

Q2 2026 holders
73
Q4 2022 holders
31
Holder diff
-42
Investor Q2 2026 Shares Q4 2022 Shares Share Diff Share Chg % Q2 2026 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .